Darzalex faspro 1,800MG-30,000 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJK7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,680
Award facts
- Contract value 100% obligated
- $45,680.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $45,680.39 to Amerisourcebergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 20, 2026, and was awarded on January 29, 2026 without set-aside designation, indicating full and open competition. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office. This delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor and critical federal vendor supplying medications and medical supplies across multiple therapeutic domains to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement needs through competitive awards, with delivery orders typically structured as firm fixed-price transactions. Through its parent company's substantial IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, Cencora, Inc. maintains a primary vehicle for delivering specialty medications, brand-name and generic drugs, vaccines, and other medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FJK7N?
SPE2DR26FJK7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FJK7N worth?
The government has obligated $45,680 on SPE2DR26FJK7N.
Is contract SPE2DR26FJK7N an order under another contract?
Yes. SPE2DR26FJK7N is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK7N competed?
The extent of competition for SPE2DR26FJK7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award